Netherlands· NL-a9f190c89da6

Apixaban Aurobindo 2,5 mg, filmomhulde tabletten

A apixaban product containing apixaban, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC B01AF02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about apixabanAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Apixaban is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AF02 (apixaban), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search apixaban products by name

Apixaban · ATC B01AF02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of apixaban costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $3.38 in France to $7.97 in Italy — a ×2.4 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Apixaban · price per daily dose (10 mg)

USD · FX 28 Sept 2026

IT Italy$7.97
CH Switzerland$4.70
FR France$3.38

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: APIXABAN
Manufacturer: Aurobindo Pharma B.V.
Country: Netherlands (NL)
ATC code: B01AF02
ATC class: Apixaban
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
125083

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

398 interactions on record for apixaban.

Graded by severity as the source publishes them — 133 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check apixaban against other medicines How interaction checks work

Apixaban · interactions on record

398 records

133 severe
224 moderate
2 minor

Most severe, free to view

LonafarnibA16AX20severe
DicoumarolB01AA01severe
WarfarinB01AA03severe
HeparinB01AB01severe

39 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Apixaban in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All apixaban products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Abatixent, Apixaban +pharma
Belgium · Apixaban Ab, Apixaban Eg
Bulgaria · Abatixent, Apixaban
Cyprus · Abidalo, Apixaban
Czechia · Aboxoma, Apixaban
Germany · Abidalo, Akkirateron
Denmark · Apinovia, Apinovia 5 Mg Film-Coated Tablets
Estonia · Abatixent, Aboxoma
Spain · Apicassa, Apiclot
Finland · Apiclodem, Apixaban
France · Apixaban, Apixaban Aet
United Kingdom (Northern Ireland) · Apixaban, Apixaban Abdi
Greece · Abixatec, Aboxoma
Croatia · Abatixent, Abidalo
Hungary · Aboxoma, Apixaban
Ireland · Apixaban Abdi, Apixaban Aristo
Iceland · Apixaban Accord, Apixaban Krka
Italy · Apilion, Apixaban Abdi
Liechtenstein · Apixaban Accord, Eliquis
Lithuania · Abatixent, Aboxoma
Luxembourg · Apixaban Eg, Apixaban Ratiopharm
Latvia · Abatixent, Aboxoma
Malta · Abidalo, Antixara
Norway · Apixaban Accord, Apixaban Axunio
Poland · Abatixent, Aboxoma
Portugal · Apixaban Grindeks, Apixabano Alter
Romania · Abatixent, Aboxoma
Sweden · Apixaban, Apixaban Axunio
Slovenia · Abatixent, Aboxoma
Slovakia · Aboxoma, Apixaban

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ec6460e9-0756-4a7a-8861-b4e2be659bb3
GET /v1/drugs/ec6460e9-0756-4a7a-8861-b4e2be659bb3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h125083_smpc.pdf",
  "strength": null,
  "atc_label": "Apixaban",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg125083",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 0-WATER",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "APIXABAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h125083.pdf",
  "authorised_at": "2021/03/15",
  "procedure_number": "PT/H/1975/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "125083",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about apixaban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console